Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Apollo Wearable on Symptoms Related to Post-acute Sequelae SARS-CoV-2 Infection (PASC).

NCT06097442 is registered in ClinicalTrials.gov with The Board of Medicine as lead sponsor.

NCT NCT06097442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06097442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Apollo Wearable on Symptoms Related to Post-acute Sequelae SARS-CoV-2 Infection (PASC).
Lead sponsor
The Board of Medicine
Phase
Observational
Overall status
Unknown status
Start date
October 23, 2023
Completion date
March 31, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-acute sequelae of sars-cov-2 infection